Followers | 74 |
Posts | 7299 |
Boards Moderated | 0 |
Alias Born | 09/09/2009 |
Thursday, December 22, 2022 10:19:19 AM
To me, that is very straightforward in saying sales start in December and will grow all year as they an manufacture more units. So I think this falls into the category of having revenues, with growth, and will attract new and bigger investors with an uplist so IMO a R/S is a great thing.
The problem with trying to get to $3 organically is that it would require a $1.5 billion market cap as an OTC stock which is mostly penny stock traders. I truly believe the only reason we are trading at .05-.06 cents is because of the investor class on the OTC markets. If this was a NYSE/NASDAQ stock we would be 10 times higher if not significantly more IMO. Therefore, the r/s is a good and much needed thing imo.
Recent ALRTF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/29/2023 12:53:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/28/2023 08:49:25 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/10/2023 09:15:16 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM